Skip to main content

A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries



Anxiety and post-traumatic stress disorder (PTSD) contribute significantly to disability adjusted life years in low- to middle-income countries (LMICs). Screening has been proposed to improve identification and management of these disorders, but little is known about the validity of screening tools for these disorders. We conducted a systematic review of validated screening tools for detecting anxiety and PTSD in LMICs.


MEDLINE, EMBASE, Global Health and PsychINFO were searched (inception-April 22, 2020). Eligible studies (1) screened for anxiety disorders and/or PTSD; (2) reported sensitivity and specificity for a given cut-off value; (3) were conducted in LMICs; and (4) compared screening results to diagnostic classifications based on a reference standard. Screening tool, cut-off, disorder, region, country, and clinical population were extracted for each study, and we assessed study quality. Accuracy results were organized based on screening tool, cut-off, and specific disorder. Accuracy estimates for the same cut-off for the same screening tool and disorder were combined via meta-analysis.


Of 6322 unique citations identified, 58 articles including 77 screening tools were included. There were 46, 19 and 12 validations for anxiety, PTSD, and combined depression and anxiety, respectively. Continentally, Asia had the most validations (35). Regionally, South Asia (11) had the most validations, followed by South Africa (10) and West Asia (9). The Kessler-10 (7) and the Generalized Anxiety Disorder-7 item scale (GAD-7) (6) were the most commonly validated tools for anxiety disorders, while the Harvard Trauma Questionnaire (3) and Posttraumatic Diagnostic Scale (3) were the most commonly validated tools for PTSD. Most studies (29) had the lowest quality rating (unblinded). Due to incomplete reporting, we could meta-analyze results from only two studies, which involved the GAD-7 (cut-off ≥10, pooled sensitivity = 76%, pooled specificity = 64%).


Use of brief screening instruments can bring much needed attention and research opportunities to various at-risk LMIC populations. However, many have been validated in inadequately designed studies, precluding any general recommendation for specific tools in LMICs. Locally validated screening tools for anxiety and PTSD need further evaluation in well-designed studies to assess whether they can improve the detection and management of these common disorders.

Trial registration

PROSPERO registry number CRD42019121794.

Peer Review reports


Mental health disorders, including anxiety and post-traumatic stress disorder (PTSD) are among the leading contributors to global disability adjusted life years, comprising five of the top twenty contributing disorders [1]. The World Health Organization International Classification of Disease (ICD-11) defines anxiety as a disorder in which there is an extreme and excessive focus on an “anticipated threat” and defines PTSD as a disorder that results from exposure to one or more “horrific events”, both of whose symptoms include apprehension, motor tension and autonomic overactivity [2]. In 2017, it was estimated that over 264 million people experienced an anxiety disorder, with the global prevalence for both anxiety disorders and PTSD ranging from 2.5 to 7% by country [2,3,4]. Both anxiety and PTSD are widespread common mental disorders (CMDs) that have been shown to cause significant negative health outcomes within various populations and contribute to a large portion of the global disease burden [5, 6]. There are noteworthy discrepancies in quality of life between people diagnosed with anxiety and/or PTSD and those who are not diagnosed with either, such as increased years lived with disability and decreased life expectancy [7,8,9]. Additionally, there is evidence suggesting that the presence of an anxiety disorder or PTSD increases the likelihood of comorbidity with other severe health conditions, such as major depressive disorder and substance use disorder [10, 11].

Anxiety and PTSD in low to middle income countries (LMICs) are highly prevalent and require further study given that access to care is hindered by availability and stigma [12,13,14]. Prevalence of these disorders is higher within LMICs; roughly 83% of people with mental illnesses globally are living within LMICs [15]. In many LMICs, there is no robust mental healthcare system in place and the number of mental health professionals is sparse [16]. Assessment and diagnosis of psychiatric illnesses thus often falls to primary care and general practitioners who have little training in mental health [16]. Use of brief screening tools have been proposed as a way to improve identification and management of mental health problems, and may be useful in LMICs, especially among populations with elevated risk (e.g., pregnant women, refugees/displaced persons, and youth) within LMIC communities [17,18,19].

Despite multiple screening instruments for CMDs, there are significantly fewer screening instruments for anxiety and PTSD that have been validated in LMIC populations. Screening instruments that have been validated exclusively in high-income countries may not perform equivalently in LMIC populations, as anxiety and PTSD often present differently in different cultural contexts. For example, in sub-Saharan Africa, anxiety and PTSD are described through somatic symptoms as well as spiritual descriptions [20]. Furthermore, differences in clinical presentation may render screening tools less accurate in LMICs. Thus, optimum cut-off scores validated in high income populations may not apply in LMIC populations. For instance, in a sample of 75 participants from Tajikistan [21], the optimal cut-off of 1.88 for the Harvard Trauma Questionnaire (HTQ), a measure of PTSD, was substantially lower than the standard cut-off score of 2.5 that has been recommended in previous studies in high-income countries [22]. Failure to apply suitable cut-off scores may lead to an imbalance of positive and negative screening results. If chosen cutoffs are too high, actual cases of anxiety and PTSD may not reach the threshold for further assessment and diagnosis; thus, cases will be missed. Conversely, if chosen cutoffs are too low, there may a very large number of positive screens requiring substantial resources for further assessment, and healthcare systems may not be able to manage the load.

Although there has been an increasing interest in studying mental health within LMICs, there are still large gaps related to screening tools to assess mental health disorders, especially anxiety and PTSD. The most recent systematic review investigating screening tools for CMDs in LMICs was published in 2016 [23]. Of the 273 validations included, 236 were validated tools for CMDs or depressive disorders while only 24 and 13 validated tools for anxiety and PTSD, respectively. Therefore, the objective of this study was to conduct a systematic review of screening tools for anxiety and PTSD within LMIC populations.


Aim: To validate screening tools for anxiety disorders and PTSD in LMICs.

We published a study protocol in advance in the PROSPERO registry (CRD42019121794).

Search strategy and study selection

We systematically searched four databases (MEDLINE, EMBASE, Global Health and PsychINFO) from inception to April 22, 2020 (see Fig. 1).

Fig. 1
figure 1

Search strategy

Inclusion criteria

Our eligibility criteria required that studies: (1) screen specifically for anxiety (generalized anxiety disorder or anxiety disorders not otherwise specified) and/or PTSD; (2) provide estimates of sensitivity and specificity for a given cut-off value for one of the included disorders; (3) were conducted in a LMIC (based on the World Bank Classification) [24]; and (4) compare screening results to a validated reference standard. Reference standards included unstructured clinical diagnostic interviews as well as structured clinical interviews including the Mini International Neuropsychiatric Interview (MINI and MINI-KID) [25], Structured Clinical Interview for DSM (SCID, SCID-1 and NetSCID) [26, 27], Composite International Diagnostic Interview (CIDI and CIDI-PHCV) [28], Clinical Interview Schedule-Revised (CIS-R) [29], Psychiatric Assessment Schedule (PAS) [30], Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS and K-SADS-PL) [31] and Clinician-Administered PTSD Scale (CAPS and CAPS-5) [32, 33]. LMIC populations residing in a LMIC at the time of study were included. No search restrictions were put on age, gender or comorbidities.

Exclusion criteria

We excluded papers that did not report sensitivity, specificity and cut-off value; that were not published in English; and that involved populations originally from an LMIC residing outside a LMIC at the time of the study. Persons from an LMIC residing in another LMIC at the time of the study were included (e.g., refugee populations and displaced persons).

Literature review

Abstracts returned from the search were reviewed separately by two independent reviewers for inclusion, with any discrepancies resolved by discussion and use of a third senior reviewer as needed. For abstracts meeting inclusion criteria, full-text articles were retrieved and reviewed by two separate reviewers for final inclusion, with discrepancies resolved by discussion and use of a third senior reviewer as needed. We also searched the reference lists of relevant systematic reviews for additional articles to add to our full-text review.

Quality appraisal

To assess study quality, we used a modified version of Greenhalgh’s ten item checklist previously used in a study by Ali et al. [23] Elements of the quality checklist are provided in Fig. 2. Credit was given for translation if a previously validated translated version of the tool or reference standard was used, or if the tool was administered in English. Studies of ‘very good’ quality fulfilled all the quality criteria. Studies deemed ‘good’ quality fulfilled criteria 1 through 3 in addition to at least one other criterion from 4 to 5. ‘Fair’ quality studies did not avoid work-up bias and ‘acceptable’ quality studies did not perform receiver operating characteristic curve (ROC) analysis to determine a normal range from the results. ‘Unblinded’ studies include studies that reported the interviewers were not blinded to the screening results; if the study did not specify whether the screening tool administrators and interviewers were blinded to each other’s results, we considered it unblinded but clarified this designation was unconfirmed.

Fig. 2
figure 2

A modified Greenhalgh’s ten item checklist, adapted from Ali et al. [23]

Data abstraction and analysis

Numerical data was abstracted by one reviewer and checked by a separate reviewer to ensure quality extraction. Data abstraction sheets included extraction of the screening tool and disorder, number of participants, DSM version, screening tool administrator, language, region, population study characteristics and age, country, gold standard, area under the curve (AUC), cut-off score, sensitivity and specificity. If multiple screening tools and/or cut-offs were used, data was extracted for each cutoff, for each tool, separately. If values were split by population, the value most representative of the total was chosen (e.g., community values for data split by hospital inpatient unit). If multiple cut-offs were given without AUC, we extracted the set of values for the cutoff that maximized Youden’s J [34]. Results were presented separately by disorder, screening tool and cut-off value. As anxiety and depression were combined in many screening tools, a third category of mixed anxiety and depression was included.

For validations of screening tools for the same disorder that used identical cut-off values, bivariate random-effects meta-analytic models were fitted to provide estimates of pooled sensitivity and specificity for the cut-off value.


Study selection

Of 6322 unique citations identified from the database search, 6188 were excluded after title and abstract review and five additional papers from the reference lists of relevant systematic reviews were added. Of 140 included for full-text review, 81 were excluded, leaving 59 eligible articles inclusive of 77 screening tools (see Fig. 3). The most common reasons for exclusion were not screening for the disorder of interest, not comparing to a gold standard, and failing to provide either sensitivity/specificity data or a threshold for screening.

Fig. 3
figure 3

Flow chart of study selection

Quality appraisal

Two studies met all the criteria of the modified Greenhalgh’s ten item checklist and deemed ‘very good’ quality while 20 studies were deemed to be ‘good’ quality, due to lack of reporting the confidence intervals for sensitivity, specificity or AUC. Two studies were ‘fair’ quality for not avoiding work-up bias and five were deemed ‘acceptable’ for failing to perform ROC analysis. A total of 29 studies were labelled ‘unblinded’ for failing to specify if they blinded the researchers or for explicitly stating they were not blinded (see Table 1).

Table 1 Quality rating statistics

Description of included studies

The final 59 studies selected included a total of 77 screening tools. There were 46 validations of screening tools for anxiety disorders, 19 for PTSD and 12 for anxiety and depression (see Table 2).

Table 2 Screening tool validation by disorder category

A minority of studies accounted for children and adolescent validations (10) despite a relatively young demographic present in LMICs [35]. The majority of validations studied adults (36), with a select few including adolescents and adults (6) (see Table 3). Particularly well-represented groups included the general population and clinical outpatients (13), perinatal populations (6), psychiatric patients (7) and those with another psychiatric comorbidity (7) (see Table 3). Of the 19 validations for PTSD, only four studied children and adolescents.

Table 3 Distribution by age a population characteristic

The majority of screening tool validations were in Asia (35) followed by Africa (20), the Americas (5) and Europe (1) (see Table 4). The best represented regions include South and West Asia, as well as South and East Africa, with a noticeable gap in Middle and Northern Africa. There were no studies from the Oceanic region.

Table 4 Number of Studies by Region and Country

The most commonly used tools to screen for generalized anxiety disorder were the Kessler-10 (K-10) and the Generalized Anxiety Disorder-7 item scale (GAD-7), totaling seven and six validations respectively. The Hopkins Symptom Checklist-25 item scale (HSCL-25), Hospital Anxiety and Depression Scale (HADS) and Hospital Anxiety and Depression Scale anxiety subscale (HADS-A) were validated almost equally while the majority of tools only had one validation (see Table 5). PTSD had far fewer validations (19) with a wide range of tools receiving between one and three validations, similar to the screening tools validated for both anxiety and depression.

Table 5 Screening Tool by Disorder and Number of Validations

Each included study is listed in Table 6 by region, screening tool and study quality with the respective sensitivity, specificity and cut-off for each disorder. Continentally, Asia had the most validations (35) and the majority of studies were considered unblinded (29). Due to incomplete reporting, we could meta-analyze results from only two studies, which involved the GAD-7; using a cut-off ≥10; sensitivity = 76%, specificity = 64%.

Table 6 Included studies listed by continent, sub-region, screening tool/disorder and quality


This review aimed to examine the screening tools that have been validated to detect anxiety and PTSD in LMICs. The most commonly validated tools were the K-10 and GAD-7 for anxiety and the HTQ and the Posttraumatic Diagnostic Scale (PDS) for PTSD. It is difficult to recommend one screening tool for anxiety and PTSD respectively, as various tools and cut-off values were tested, and sensitivities and specificities varied based on region, country and screening tool. Indeed, only two studies tested the same tool using the same cut-off value and reported sufficient information to allow us to quantitatively synthesize the results. Locally validated screening tools for anxiety and PTSD need further evaluation in well-designed studies to assess whether they can improve the detection and management of these common disorders.

A total of 46 validated screening tools were found for anxiety disorders. The most common tool used to screen for anxiety disorders was the Kessler-10 followed by the GAD-7, which had wide ranges of sensitivities (57–94%) and specificities (53–94%) varying by region and sample size. While previously the HADS-A was recommended [23], our updated review found that it was not as widely validated as the GAD-7 and Kessler-10, although it had consistent specificities (72–79%) with a range of sensitivities (38–86%). The Kessler may have an added time-efficiency component, as it is possible to screen for multiple common mental disorders, whereas screening tools such as the HADS-A target anxiety specifically. The GAD-7 reported some of the highest sensitivities for detection of generalized anxiety disorder. Other anxiety disorders, including agoraphobia, panic disorder and social anxiety disorder were less commonly validated. Our results are consistent with a previous systematic review [23] and indicate using the GAD-7, K-10 or HAD-A yield good sensitivities and specificities while taking population-specific characteristics into account. Future research is needed to validate screening tools for these anxiety disorders in more regions.

The number of validations for PTSD increased from 10 to 19 since 2013 [23]. The HTQ and PDS were the most commonly validated tools for PTSD, and sensitivities were generally high. Our findings add that in addition to the previously recommended HTQ, the PDS should be considered in screening for PTSD [23]. Unfortunately, many tools were validated only once, preventing our combining them for analytic purposes. Only four PTSD validations describe children and adolescents, despite recent events that have displaced thousands of youth [93]. The prevalence of PTSD remains high in LMICs and is expected to rise given increasing civil unrest and war [19, 94]. The year 2018 saw the highest recorded number of displaced persons globally leading the authors to emphasize more attention into detection and treatment of PTSD [95].

Anxiety and depression had the fewest validations across our search [11] though were not the target of our validation given the existing literature on depression alone [23]. All tools with the exception of the HSCL-25 had only one validation. The only independently developed screening tool of all the studies was for anxiety and depression, developed in Zambia. These disorders commonly occur together, and further research is needed to determine which tools are best suited to a region’s mental health screening needs.

We searched four databases with a robust library of psychiatric publications available. We also placed minimal exclusion criteria on our searches so as to maximize the number of studies returned, and we additionally reviewed relevant systematic reviews for additional relevant papers. At every stage of the process from title/abstract screen to data abstraction, two reviewers assessed each article and numerical data point to reduce human error. Our search strategy and protocol were published in PROSPERO and were not altered from the time of submission, with the exception that we did not calculate diagnostic odds ratios (DORs), as they provide no guidance to clinicians on what screening tool and cut-off threshold would be most appropriate to use in clinical practice. Rather, we reported sensitivity and specificity of each screening tool and cutoff separately, to better describe the accuracies of individual tools and cut-offs.

Our extraction was limited by the individual papers’ specific data reporting. Varying prevalence of an individual study may affect the cut-off score, sensitivity and specificity of screening tools, and some studies did not publish prevalence. Providers should reference the prevalence of each specific disorder to ascertain whether the cut-off is applicable to their respective population. The majority of studies did not provide sensitivities and specificities for multiple cut-off values. Reporting multiple cut-off values and their respective sensitivity and specificity estimates would allow providers to decide which cut-off they would choose to optimize screening for their setting. A lower cut-off with a higher sensitivity may be desired if cases are not to be missed and false negatives reduced. A higher cut-off with a higher specificity may be desired if false positives are to be minimized. Furthermore, reporting multiple cut-off values and their respective sensitivity and specificity estimates would also allow researchers to better synthesize accuracy results across multiple studies in meta-analysis. In the present study, only two validations with identical cut-off scores for the GAD-7 could be combined via meta-analysis as no other validations of the same disorder with identical cut-off values provided sufficient information to conduct a meta-analysis (i.e., 2 × 2 table numbers). Studies used various versions of the DSM and ICD. While the symptomatology for psychiatric diagnoses have not changed significantly, providers should reference which version was used when conducting the validation of the screening tool (see Table 6).

Our review was also limited by the available publications on mental health screenings in LMICs. The entire region of Middle and North Africa, constituting over 300 million people, was not represented by a single validation while other regions such as South-East Asia were fairly well-represented. Cultural and linguistic factors may influence screening tool validation yet further discussion may be best served for individual validation papers. Most studies were rated in the lowest quality category of the modified Greenhalgh scale as they were unblinded, or downgraded to unblinded due to incomplete reporting. This is a severe limitation in the design of studies that may impact validation results; future studies should ensure adequate blinding in addition to the remainder of the quality checklist.

Our study did not look at CMDs or depression specifically, although we did consider anxiety and depression when screened for together. We chose to focus on anxiety and PTSD as they are less well-represented in the realm of LMIC validated screening tools. Additionally, anxiety and PTSD are becoming more important with the current displacement of millions of people due to civil unrest, socioeconomic upheaval and war.

The number of validated screening tools for mental health disorders as a whole has increased since 2013 [23]. However, no large increase in the number of validations for specific disorders was seen, and most screening tools from our search were validated only once. We advise researchers and providers to refer to Table 6 for a summary of validations for locations and disorders of interest and to use this table to identify their region of interest, find their disease focus of interest, and then identify what tools have been identified by the highest quality evidence.


Mental health disorders are highly prevalent yet are frequently stigmatized and disregarded as medical diseases. Validated screening tools for anxiety and PTSD in LMIC have made considerable progress, with validations for both disorders almost doubling since the prior systematic review completed in December 2013 [23]. The increase in validated screening tools generally followed a regional pattern, with more emerging in countries already represented. For example, more tools have been validated in South Africa without an increase in validations in Botswana, Lesotho, Namibia or Swaziland. Middle and Northern Africa were also not well-represented by either anxiety or PTSD screening tools. The authors recognize that it may be near impossible to validate screening tools in areas of intense conflict and instability but acknowledge the need to evaluate screening tools in these areas.

The age distribution among screening tools was heavily biased towards the adult population. Children and adolescents accounted for only four of 19 validations for PTSD and six of 58 for anxiety and anxiety and depression. Given that age is skewed towards a younger population in LMICs [35], it is imperative that more research focuses on identifying anxiety and PTSD disorders in a pediatric population, especially in areas of increased civil war and conflict.

Use of brief screening instruments can bring much needed attention and research opportunities to various at-risk populations in LMICs. Many screening tools for anxiety and PTSD have been validated in LMICs, but there remain regions and subgroups of individuals for which more research is needed. Locally validated screening tools for anxiety and PTSD should be further evaluated in clinical trials to determine whether their use can reduce the burden of disease.

Availability of data and materials

All data generated or analysed during this study are included in this published article [and its supplementary information files].



Post-traumatic stress disorder


Low to middle income countries


Common mental disorders


Mini International Neuropsychiatric Interview


Structured Clinical Interview for DSM


Composite International Diagnostic Interview


Clinical Interview Schedule-Revised


Psychiatric Assessment Schedule


Kiddie Schedule for Affective Disorders and Schizophrenia

CAPS and CAPS-5:

Clinician-Administered PTSD Scale


Area under the curve


Receiver operating characteristic curve


Diagnostic odds ratios


Hospital Anxiety and Depression Scale


Depression Anxiety Stress Scales

Zung SAS:

Zung Self-Rating Anxiety Scale


State Trait Anxiety Inventory


Edinburgh Postnatal Depression Scale


Hamilton Anxiety Rating Scale


Kessler 10/6


Generalized Anxiety Test


Hamilton Depression Rating Scale


Hopkins Symptom Checklist


Mini-Social Phobia Inventory


Primary Health Care Screening Tool


General Health Questionnaire


Screen for Child Anxiety Related Disorders


Perinatal Anxiety Screening Scale


Revised Children’s Anxiety and Depression Scales


Beck Anxiety Inventory


Harvard Trauma Questionnaire


Posttraumatic Diagnostic Scale


PTSD Checklist-Clinician Version


Child PTSD Symptom Scale


Traumatic Stress Symptom Scale


Clinician-Administered PTSD Scale


Youth Self-Report


Aga Khan University Anxiety and Depression


Self-Reporting Questionnaire


Arab Youth Mental Health Scale


Huaxi Emotional-Distress Index


  1. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386(9995):743–800.

    Article  Google Scholar 

  2. Hannah Ritchie and Max Roser. (2018). Mental Health. Published online at . Retrieved from: '' [online resource].

    Google Scholar 

  3. Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013;43(5):897–910.

    Article  CAS  PubMed  Google Scholar 

  4. Koenen KC, Ratanatharathorn A, Ng L, McLaughlin KA, Bromet EJ, Stein DJ, et al. Posttraumatic stress disorder in the world mental Health surveys. Psychol Med. 2017;47(3):2260–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Atwoli L, Stein DJ, Koenen KC, Mclaughlin KA, Health M, Africa S. Epidemiology of posttraumatic stress disorder: prevalence, correlates and consequences. Curr Opin Psychiatry. 2015;28(4):307–11.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bitsko RH, Holbrook JR, Ghandour RM, Blumberg SJ, Visser SN, Perou R, et al. Epidemiology and impact of health care provider-diagnosed anxiety and depression among. US children. 2019;39(5):395–403.

    Article  Google Scholar 

  7. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications. JAMA Psychiatry. 2015;72(4):334.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Whiteford HA, Ferrari AJ, Degenhardt L, Feigin V, Vos T. The global burden of mental, neurological and substance use disorders: An analysis from the global burden of disease study 2010. PLoS One. 2015;10(2):1–14.

    Article  CAS  Google Scholar 

  9. Forbes D, McFarlane AC, Silove D, Bryant RA, O’Donnell ML, Creamer M. The lingering impact of resolved PTSD on subsequent functioning. Clin Psychol Sci. 2015;4(3):493–8.

    Article  Google Scholar 

  10. Brady K, Killeen T, Brewerton T, Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000;61:22–32.

    Article  Google Scholar 

  11. Sheffler JL, Rushing NC, Stanley IH, Sachs-Ericsson NJ. The long-term impact of combat exposure on health, interpersonal, and economic domains of functioning. Aging Ment Health. 2016;20(11):1202–12.

    Article  PubMed  Google Scholar 

  12. Kane JC, Elafros MA, Murray SM, Mitchell EMH, Augustinavicius JL, Causevic S, Baral SD. A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries. BMC Med. 2019;17(1).

  13. Mascayano F, Armijo JE, Yang LH. Addressing stigma relating to mental illness in low- and middle-income countries. Front Psychiatry. 2015;6(38):1–4.

    Article  Google Scholar 

  14. Wainberg ML, Scorza P, Shultz JM, Helpman L, Mootz JJ, Johnson KA, et al. Challenges and opportunities in global mental Health: a research-to-practice perspective. Curr Psychiatry Rep. 2017;19(5).

  15. World Health Organization. The global burden of disease 2004, vol. 146. Geneva: Update, World Health Organization; 2004.

  16. Nadkarni A, Hanlon C, Bhatia U, Fuhr D, Ragoni C, de Azevedo Perocco SL, et al. The management of adult psychiatric emergencies in low-income and middle-income countries: a systematic review. Lancet Psychiatry. 2015;2(6):540–7.

    Article  PubMed  Google Scholar 

  17. Giacco D, Laxhman N, Priebe S. Prevalence of and risk factors for mental disorders in refugees. Semin Cell Dev Biol. 2018;77:144–52.

    Article  PubMed  Google Scholar 

  18. Honikman S, Tomlinson M, Field S, van Heyningen T, Myer L, Onah MN. Prevalence and predictors of anxiety disorders amongst low-income pregnant women in urban South Africa: a cross-sectional study. Arch Womens Mental Health. 2017;20(6):765–75.

    Article  Google Scholar 

  19. Yatham S, Sivathasan S, Yoon R, da Silva TL, Ravindran AV. Depression, anxiety, and post-traumatic stress disorder among youth in low and middle income countries: a review of prevalence and treatment interventions. Asian J Psychiatr. 2018;38(August 2017):78–91.

    Article  PubMed  Google Scholar 

  20. Lloyd K, Simunyu E, Mann A, Patel V, Gwanzura F. The phenomenology and explanatory models of common mental disorder: a study in primary care in Harare, Zimbabwe. Psychol Med. 2009;25(06):1191.

    Article  Google Scholar 

  21. Hollander AC, Ekblad S, Mukhamadiev D, Muminova R. The validity of screening instruments for posttraumatic stress disorder, depression, and other anxiety symptoms in Tajikistan. J Nerv Ment Dis. 2007;195(11):955–8.

    Article  PubMed  Google Scholar 

  22. Mollica R, Caspi-Yavin Y, Bollini P, Truong T, Tor S, Lavelle J. The Harvard trauma questionnaire: validating a cross-cultural instrument for measuring torture, trauma, and posttraumatic stress disorder in indochinese refugees. J Nerv Ment Dis. 1992;180(2):111–6.

    Article  CAS  Google Scholar 

  23. Ali GC, Ryan G, De Silva MJ. Validated screening tools for common mental disorders in low and middle income countries: a systematic review. PLoS One. 2016;11(6):1–14.

    Article  CAS  Google Scholar 

  24. The World Bank. World Bank Country and Lending Groups Website. Accessed December 3, 2018.

  25. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.

    PubMed  Google Scholar 

  26. Spitzer R, Williams J, Gibbon M, First M. The structured clinical interview for DSM-III-R (SCID). Arch Gen Psychiatry. 1992;49:624–9.

    Article  CAS  Google Scholar 

  27. Brodey BB, First M, Linthicum J, Haman K, Sasiela JW, Ayer D. Validation of the NetSCID: An automated web-based adaptive version of the SCID. Compr Psychiatry. 2016;66:67–70.

    Article  PubMed  Google Scholar 

  28. Robins L, Wing J, Wittchen HU, Helzer J, Babor T, Burke J, et al. The composite international diagnostic interview (CIDI). Arch Gen Psychiatry. 1988;45:1069–77.

    Article  CAS  PubMed  Google Scholar 

  29. Lewis G, Pelosi A, Araya R, Dunn G. Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers. Psychol Med. 1992;22(May):465–86.

    Article  CAS  Google Scholar 

  30. Moss S, Patel P, Prosser H, Goldberg D, Simpson N, Rowe S, Lucchino R. Psychiatric morbidity in older people with moderate and severe learning disability. I: development and reliability of the patient interview (PAS-ADD). Br J Psychiatry. 1993;163(OCT):471–80.

    Article  CAS  PubMed  Google Scholar 

  31. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–8.

    Article  CAS  PubMed  Google Scholar 

  32. Blake DD, Weathers F, Nagy L, Kaloupek D, Gusman F, Charney D, Keane T. The development of a clinician-administered PTSD scale. J Trauma Stress. 1995;8(1):75–90.

    Article  CAS  Google Scholar 

  33. Weathers F, Bovin M, Lee D, Sloan D, Schnurr P, Kaloupek D, et al. The clinician-administered PTSD scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383–95.

    Article  PubMed  Google Scholar 

  34. Ruopp M, Perkins N, Whitcomb B, Schisterman E. Youden index and optimal cut-point estimated from observations affected by a lower limit od detection. Biom J. n.d.;50(3):419–30.

  35. Sudharsanan N, Bloom D. The demography of aging in low- and middle-income countries: chronological versus functional perspectives. In: Hayward M, Majmundar M, editors. Future directions for the demography of aging. Washington, DC: The National Academies Press; 2018. p. 322–51.

    Chapter  Google Scholar 

  36. Goldberg DP, Reed GM, Robles R, Minhas F, Razzaque B, Fortes S, et al. Screening for anxiety, depression, and anxious depression in primary care: a field study for ICD-11 PHC. J Affect Disord. 2017;213(February):199–206.

    Article  PubMed  Google Scholar 

  37. Ventevogel P, Komproe IH, Jordans MJ, Feo P, De Jong JTVM. Validation of the Kirundi versions of brief self-rating scales for common mental disorders among children in Burundi. BMC Psychiatry. 2014;14(1):1–13.

    Article  Google Scholar 

  38. Chibanda D, Verhey R, Gibson LJ, Munetsi E, Machando D, Rusakaniko S, et al. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. J Affect Disord. 2016;198:50–5.

    Article  PubMed  Google Scholar 

  39. Kaaya SF, Fawzi MCS, Mbwambo JK, Lee B, Msamanga GI, Fawzi W. Validity of the Hopkins symptom Checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand. 2002;106(1):9–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Verhey R, Chibanda D, Gibson L, Brakarsh J, Seedat S. Validation of the posttraumatic stress disorder checklist - 5 (PCL-5) in a primary care population with high HIV prevalence in Zimbabwe. BMC Psychiatry. 2018;18(1):1–8.

    Article  Google Scholar 

  41. Odenwald M, Lingenfelder B, Schauer M, Neuner F, Rockstroh B, Hinkel H, Elbert T. Screening for posttraumatic stress disorder among Somali ex-combatants: a validation study. Confl Heal. 2007;1(1):1–9.

    Article  Google Scholar 

  42. Ertl V, Pfeiffer A, Saile R, Schauer E, Elbert T, Neuner F. Validation of a mental health assessment in an african conflict population. Psychol Assess. 2010;22(2):318–24.

    Article  PubMed  Google Scholar 

  43. Mbewe EK, Uys LR, Nkwanyana NM, Birbeck GL. A primary healthcare screening tool to identify depression and anxiety disorders among people with epilepsy in Zambia. Epilepsy Behavior. 2013;27(2):296–300.

    Article  CAS  PubMed  Google Scholar 

  44. Geibel S, Habtamu K, Mekonnen G, Jani N, Kay L, Shibru J, et al. Reliability and validity of an interviewer-administered adaptation of the youth self-report for mental health screening of vulnerable young people in Ethiopia. PLoS One. 2016;11(2):1–15.

    Article  CAS  Google Scholar 

  45. Saal WL, Kagee A, Bantjes J. Evaluation of the beck anxiety inventory in predicting generalised anxiety disorder among individuals seeking HIV testing in the Western Cape Province, South Africa. S Afr J Psychiatry. 2019;25:1–5.

    Article  Google Scholar 

  46. van Heyningen T, Honikman S, Tomlinson M, Field S, Myer L. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in south African women. PLoS One. 2018;13(4):1–18.

    Article  CAS  Google Scholar 

  47. Marsay C, Manderson L, Subramaney U. Validation of the Whooley questions for antenatal depression and anxiety among low-income women in urban South Africa. S Afr J Psychiatry. 2017;23(1):1–7.

    Article  Google Scholar 

  48. Seedat S, Fritelli V, Oosthuizen P, Emsley RA, Stein DJ. Measuring anxiety in patients with schizophrenia. J Nerv Ment Dis. 2007;195(4):320–4.

    Article  PubMed  Google Scholar 

  49. Myer L, Smit J, Le Roux L, Parker S, Stein DJ, Seedat S. Common mental disorders among HIV-infected individuals in South Africa: prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care STDs. 2008;22(2):147–58.

    Article  PubMed  Google Scholar 

  50. Spies G, Kader K, Kidd M, Smit J, Myer L, Stein DJ, Seedat S. Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care. 2009;21(9):1163–8.

    Article  CAS  PubMed  Google Scholar 

  51. Andersen LS, Grimsrud A, Meyer L, Williams DR, Stein DJ, Seedat S. The psychometric properties of the K10 and K6 scales in screening for mood and anxiety disorders in the south African stress and Health study. Int J Methods Psychiatr Res. 2011;20(4):215–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Spies G, Stein DJ, Roos A, Faure SC, Mostert J, Seedat S, Vythilingum B. Validity of the Kessler 10 (K-10) in detecting DSM-IV defined mood and anxiety disorders among pregnant women. Arch Womens Mental Health. 2009;12(2):69–74.

    Article  CAS  Google Scholar 

  53. Martin L, Fincham D, Kagee A. Screening for HIV-related PTSD: sensitivity and specificity of the 17-item posttraumatic stress diagnostic scale (PDS) in identifying HIV-related PTSD among a south African sample. Afr J Psychiatry (South Africa). 2009;12(4):270–4.

    Article  CAS  Google Scholar 

  54. van der Westhuizen C, Wyatt G, Williams JK, Stein DJ, Sorsdahl K. Validation of the self reporting questionnaire 20-item (SRQ-20) for use in a low- and middle-income country emergency Centre setting. Int J Ment Heal Addict. 2016;14(1):37–48.

    Article  Google Scholar 

  55. Makanjuola VA, Onyeama M, Nuhu FT, Kola L, Gureje O. Validation of short screening tools for common mental disorders in Nigerian general practices. Gen Hosp Psychiatry. 2014;36(3):325–9.

    Article  PubMed  Google Scholar 

  56. Abiodun AO. A validity study of the hospital anxiety and depression scale in general hospital units and a community sample in Nigeria. Br J Psychiatry. 1994;165(5):669–72.

    Article  CAS  Google Scholar 

  57. Tong X, An D, McGonigal A, Park SP, Zhou D. Validation of the generalized anxiety Disorder-7 (GAD-7) among Chinese people with epilepsy. Epilepsy Res. 2016;120(February 2020):31–6.

    Article  PubMed  Google Scholar 

  58. Sheng L. Better detection of non-psychotic mental disorders by case description method in China. Asian J Psychiatr. 2010;3(4):227–32.

    Article  PubMed  Google Scholar 

  59. Yang Y, Ding R, Hu D, Zhang F, Sheng L. Reliability and validity of a Chinese version of the HADS for screening depression and anxiety in psycho-cardiological outpatients. Compr Psychiatry. 2014;55(1):215–20.

    Article  PubMed  Google Scholar 

  60. Wang J, Guo W, Jun Zhang L, Deng W, Wang H, Yao Y, Ying J, et al. The development and validation of Huaxi emotional-distress index (HEI): a Chinese questionnaire for screening depression and anxiety in non-psychiatric clinical settings. Compr Psychiatry. 2017;76:87–97.

    Article  CAS  PubMed  Google Scholar 

  61. Liu A, Tan H, Zhou J, Li S, Yang T, Tang X, et al. A short DSM-IV screening scale to detect posttraumatic stress disorder after a natural disaster in a Chinese population. Psychiatry Res. 2008;159(3):376–81.

    Article  PubMed  Google Scholar 

  62. Liu AZ, Tan H, Zhou J, Li S, Yang T, Sun Z, Wen SW. Brief screening instrument of posttraumatic stress disorder for children and adolescents 7-15 years of age. Child Psychiatry Hum Dev. 2007;38(3):195–202.

    Article  PubMed  Google Scholar 

  63. Ali BS, Amanullah S. A comparative review of two screening instruments; the Aga Khan University anxiety and depression scale and the self reporting questionnaire. J Pak Med Assoc. 1998;48(3):79–82.

    CAS  PubMed  Google Scholar 

  64. Kohrt BA, Kunz RD, Koirala NR, Sharman VD, Nepal MK. Validation of the Nepali version of beck anxiety inventory. J Inst Med. 2003;25(3):1–4.

    Google Scholar 

  65. Thapa SB, Hauff E. Psychological distress among displaced persons during an armed conflict in Nepal. Soc Psychiatry Psychiatr Epidemiol. 2005;40(8):672–9.

    Article  PubMed  Google Scholar 

  66. Kohrt BA, Jordans MJ, Tol WA, Luitel NP, Maharjan SM, Upadhaya N. Validation of cross-cultural child mental health and psychosocial research instruments: adapting the depression self-rating scale and child PTSD symptom scale in Nepal. BMC Psychiatry. 2011;11(127):1–17.

    Article  Google Scholar 

  67. Chaturvedi SK, Chandra PS, Channabasavanna SM, Beena MB. Detection of anxiety and depression in cancer patients. NIMHANS J. 1994;12(2):141–4.

    Google Scholar 

  68. Ventevogel P, De Vries G, Scholte WF, Shinwari NR, Faiz H, Nassery R, et al. Properties of the Hopkins symptom checklist-25 (HSCL-25) and the self-reporting questionnaire (SRQ-20) as screening instruments used in primary care in Afghanistan. Soc Psychiatry Psychiatr Epidemiol. 2007;42(4):328–35.

    Article  PubMed  Google Scholar 

  69. Housen T, Lenglet A, Ariti C, Ara S, Shah S, Dar M, et al. Validation of mental health screening instruments in the Kashmir Valley, India. Transcult Psychiatry. 2018;55(3):361–83.

    Article  PubMed  Google Scholar 

  70. Ahmadi SM, Arani AM, Bakhtiari M, Davazdah Emamy MH. Psychometric properties of Persian version of patient health questionnaires-4 (PHQ-4) in coronary heart disease patients. Iran J Psychiatry Behav Sci. 2020;13(4).

  71. Russell PSS, Nair MKC, Russell S, Subramaniam VS, Sequeira AZ, Nazeema S, George B. ADad 2: the validation of the screen for child anxiety related emotional disorders for anxiety disorders among adolescents in a rural community population in India. Indian J Pediatr. 2013;80(November):S139–43.

    Article  PubMed  Google Scholar 

  72. Namazi S, Baba MB, Mokhtar HH, Hamzah MSG. Validation of the Iranian version of the University of California at Los Angeles posttraumatic stress disorder index for DSM-IV-R. Trauma Monthly. 2013;18(3):122–5.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Tran TD, Fisher J, Tran T. Validation of the depression anxiety stress scales ( DASS ) 21 as a screening instrument for depression and anxiety in a rural ... Validation of the depression anxiety stress scales ( DASS ) 21 as a screening instrument for depression and anxiety in a rur. BMC Psychiatry. 2013;13(24):1–7.

    Article  Google Scholar 

  74. Sidik SM, Arroll B, Goodyear-Smith F. Validation of the GAD-7 (Malay version) among women attending a primary care clinic in Malaysia. J Primary Health Care. 2012;4(1):5–11.

    Article  Google Scholar 

  75. Yahya F, Othman Z, Fariza Yahya M. Validation of the Malay version of hospital anxiety and depression scale (HADS) in Hospital Universiti Sains Malaysia article in. Int Med J Yol. 1994;22(2):80–2.

    Google Scholar 

  76. Silove D, Manicavasagar V, Mollica R, Thai M, Khiek D, Lavelle J, Tor S. Screening for depression and PTSD in a Cambodian population unaffected by war: comparing the Hopkins symptom checklist and Harvard trauma questionnaire with the structured clinical interview. J Nerv Ment Dis. 2007;195(2):152–7.

    Article  PubMed  Google Scholar 

  77. Tran TD, Kaligis F, Wiguna T, Willenberg L, Nguyen HTM, Luchters S, et al. Screening for depressive and anxiety disorders among adolescents in Indonesia: formal validation of the Centre for epidemiologic studies depression scale – revised and the Kessler psychological distress scale. J Affect Disord. 2019;246(August 2018):189–94.

    Article  PubMed  Google Scholar 

  78. Tran TD, Tran T, La B, Lee D, Rosenthal D, Fisher J. Screening for perinatal common mental disorders in women in the north of Vietnam: a comparison of three psychometric instruments. J Affect Disord. 2011;133(1–2):281–93.

    Article  PubMed  Google Scholar 

  79. Tran TD, Tran T, Fisher J. Validation of three psychometric instruments for screening for perinatal common mental disorders in men in the north of Vietnam. J Affect Disord. 2012;136(1–2):104–9.

    Article  PubMed  Google Scholar 

  80. Mahfoud Z, Abdulrahim S, Taha MB, Harpham T, El Hajj T, Makhoul J, et al. Validation of the Arab youth mental Health scale as a screening tool for depression/anxiety in Lebanese children. Child Adolesc Psychiatry Ment Health. 2011;5:1–7.

    Article  Google Scholar 

  81. Sawaya H, Atoui M, Hamadeh A, Zeinoun P, Nahas Z. Adaptation and initial validation of the patient Health questionnaire - 9 (PHQ-9) and the generalized anxiety disorder - 7 questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Res. 2016;239:245–52.

    Article  PubMed  Google Scholar 

  82. Senturk V, Stewart R, Sagduyu A. Screening for mental disorders in leprosy patients: comparing the internal consistency and screening properties of HADS and GHQ-12. Lepr Rev. 2007;78(3):231–42.

    PubMed  Google Scholar 

  83. Malasi TH, Mirza IA, El-Islam MF. Validation of the hospital anxiety and depression scale in Arab patients. Acta Psychiatr Scand. 1991;84(4):323–6.

    Article  CAS  PubMed  Google Scholar 

  84. Yazıcı E, Mutu Pek T, Uslu Yuvacı H, Köse E, Cevrioglu S, Yazıcı AB, et al. Perinatal anxiety screening scale validiy and reliability study in Turkish (PASS-TR validity and reliability). Psychiatry Clin Psychopharmacol. 2019;29(4):609–17.

    Article  Google Scholar 

  85. Ibrahim H, Ertl V, Catani C, Ismail AA, Neuner F. The validity of posttraumatic stress disorder checklist for DSM-5 (PCL-5) as screening instrument with Kurdish and Arab displaced populations living in the Kurdistan region of Iraq. BMC Psychiatry. 2018;18(1):1–8.

    Article  Google Scholar 

  86. Gormez V, Kılınçaslan A, Orengul AC, Ebesutani C, Kaya I, Ceri V, et al. Psychometric properties of the Turkish version of the revised child anxiety and depression scale – child version in a clinical sample. Psychiatry Clin Psychopharmacol. 2017;27(1):84–92.

    Article  Google Scholar 

  87. Hariz N, Bawab S, Atwi M, Tavitian L, Zeinoun P, Khani M, et al. Reliability and validity of the Arabic screen for child anxiety related emotional disorders (SCARED) in a clinical sample. Psychiatry Res. 2013;209(2):222–8.

    Article  PubMed  Google Scholar 

  88. Başoglu M, Şalcioglu E, Livanou M, Özeren M, Aker T, Kiliç C, Mestçioglu Ö. A study of the validity of a screening instrument for traumatic stress in earthquake survivors in Turkey. J Trauma Stress. 2001;14(3):491–509.

    Article  PubMed  Google Scholar 

  89. Oruc L, Kapetanovic A, Pojskic N, Miley K, Forstbauer S, Mollica RF, Henderson DC. Screening for PTSD and depression in Bosnia and Herzegovina: validating the Harvard trauma questionnaire and the Hopkins symptom checklist. Int J Cult Ment Health. 2008;1(2):105–16.

    Article  Google Scholar 

  90. Zhong QY, Gelaye B, Zaslavsky AM, Fann JR, Rondon MB, Sánchez SE, Williams MA. Diagnostic validity of the generalized anxiety disorder - 7 (GAD-7) among pregnant women. PLoS One. 2015;10(4):1–17.

    Article  CAS  Google Scholar 

  91. de Lima Osório F, Crippa JA, Loureiro SR. A study of the discriminative validity of a screening tool (MINI-SPIN) for social anxiety disorder applied to Brazilian university students. Eur Psychiatry. 2007;22(4):239–43.

    Article  PubMed  Google Scholar 

  92. Gelaye B, Zheng Y, Medina-Mora ME, Rondon MB, Sánchez SE, Williams MA. Validity of the posttraumatic stress disorders (PTSD) checklist in pregnant women. BMC Psychiatry. 2017;17(1):1–10.

    Article  Google Scholar 

  93. Vossoughi N, Jackson Y, Gusler S, Stone K. Mental Health outcomes for youth living in refugee camps: a review. Trauma Violence Abuse. 2018;19(5):528–42.

    Article  PubMed  Google Scholar 

  94. Kessler RC, Aguilar-Gaxiola S, Alonso J, Benjet C, Bromet EJ, Cardoso G, Degenhardt L, de Girolamo G, Dinolova RV, Ferry F, Florescu S, Gureje O, Haro JM, Huang Y, Karam EG, Kawakami N, Lee S, Lepine J, Levinson D, Navarro-Mateu F, Pennell B, Piazza M, Posada-Villa J, Scott KM, Stein DJ, Zaslavsky AM, Koenen KC. Trauma and PTSD in the WHO world mental Health surveys. Eur J Psychotraumatol. 2017;8(sup5):1353383.

    Article  PubMed  PubMed Central  Google Scholar 

  95. UNHCR. Global Trends: the world at war. 2018.

Download references


Rebecca McCall (search strategy aid), UNC Chapel Hill.


The Doris Duke Clinical Research Foundation funded the primary author, Ms. Mughal, for the design of the study and collection, analysis, and interpretation of data and in writing the manuscript through a Doris Duke International Clinical Research Fellowship. Dr. Levis was supported by a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarship doctoral award, and a Fonds de recherche du Québec - Santé (FRQS) Postdoctoral Training Fellowship.

Author information

Authors and Affiliations



All authors listed below have read and approved the manuscript. AYM: Design of systematic review, search criteria and primary reviewer, wrote manuscript. JD: Primary reviewer, aided in introduction and editing of manuscript. EA: Primary reviewer, aided in manuscript writing and editing. BL: Data analysis, aided in manuscript writing and editing. VFG: Manuscript writing and editing. 6. BNG: Design of systematic review, development of methods, manuscript writing and editing.

Corresponding author

Correspondence to Bradley N. Gaynes.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mughal, A.Y., Devadas, J., Ardman, E. et al. A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries. BMC Psychiatry 20, 338 (2020).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: